Dashboard
High Management Efficiency with a high ROCE of 28.59%
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0 times
Poor long term growth as Operating profit has grown by an annual rate -1.80% of over the last 5 years
Positive results in Sep 26
Stock is technically in a Mildly Bearish range
With ROCE of 25, it has a Attractive valuation with a 4.5 Enterprise value to Capital Employed
Majority shareholders : Promoters
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Nov-14-2025
Risk Adjusted Returns v/s 
Returns Beta
News

GPT Healthcare Ltd is Rated Hold by MarketsMOJO
GPT Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 October 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 November 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
GPT Healthcare Ltd Valuation Turns Attractive Amid Sector Comparisons
GPT Healthcare Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by a recalibration of its price-to-earnings and price-to-book value ratios. This change comes amid a challenging market backdrop for hospital sector stocks, where GPT Healthcare’s micro-cap status and recent performance contrast with broader indices and peer valuations.
Read More
GPT Healthcare Ltd is Rated Hold by MarketsMOJO
GPT Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 26 October 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 10 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14-Nov-2026 | Source : BSEPlease find enclosed herewith Earnings Call Transcript.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
06-Nov-2026 | Source : BSEPlease find enclosed herewith audio call recording of Earnings call for Q2H1FY27.
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSEPlease find enclosed herewith copies of the News Paper publication on Un-Audited Financial Results for Q2 & H1 FY 27 and Notice of Record Date.
Corporate Actions 
No Upcoming Board Meetings
GPT Healthcare Ltd has declared 10% dividend, ex-date: 12 Nov 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (4.61%)
Held by 8 FIIs (3.0%)
Gpt Sons Private Limited (65.57%)
Bandhan Small Cap Fund (4.61%)
18.1%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 7.46% vs -0.13% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 20.97% vs -12.63% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 11.08% vs -0.34% in Sep 2024
Growth in half year ended Sep 2025 is -26.22% vs 5.53% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 13.25% vs 1.64% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -25.32% vs 5.95% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 16.08% vs 1.72% in Mar 2025
YoY Growth in year ended Mar 2026 is -15.42% vs 4.50% in Mar 2025